Doug Hampton 
G FUEL Traveler’s Ale is Available at GFUEL.com While Supplies Last NEW YORK, June 21, 2023 /PRNewswire/ — G FUEL, in partnership with HoYoverse, announced today that its new Traveler’s Ale flavor inspired by the wildly popular open-world adventure RPG Genshin Impact is now available for pre-order in Collector’s Boxes and Tubs at GFUEL.com while supplies … Read more
DENVER, June 21, 2023 /PRNewswire/ — Ahead of the Fourth of July, Pet Releaf is sharing expert tips, resources, and CBD products to help keep pets calm and safe during fireworks. While the holiday weekend is the highlight of summer for many families, it also comes with a not-so-fun statistic: thousands of pets will go … Read more
Heat Waves are the #1 Cause of Weather-Related Deaths in the U.S. AccuWeather Introduces the Only Scale that Tracks the Duration and Severity of Heat Waves, Allowing People to Now Easily Compare the Intensity of Current and Previous Heat Waves STATE COLLEGE, Pa., June 21, 2023 /PRNewswire/ — AccuWeather®, the undisputed leader in Superior Accuracy™ … Read more
The Nod Confirms Therabody as Clear Leader in Wellness LOS ANGELES, June 21, 2023 /PRNewswire/ — Therabody, the global pioneer in wellness technology, proudly announces its inclusion in The 2023 TIME100 Most Influential Companies, a list that celebrates companies that are making an extraordinary impact around the world. TIME100 Most Influential Companies 2023 The TIME100 … Read more
FDA Clearance received 60 days from submission and paves way for Commercialization in the United States KFAR SABA, Israel, June 21, 2023 /PRNewswire/ — VVT Medical, a global medical device company, announces today the receipt of a 510(k) clearance for its ScleroSafe™ platform by the U.S. Food and Drug Administration (FDA). ScleroSafe advanced technology by VVT … Read more
The current therapeutic landscape of hemophilia in the United States is driven by several approved therapies. The hemophilia market is estimated to grow for the period 2019-2032. The major reason behind the hemophilia market upsurge is the launch of the most anticipated gene therapies, which are considered as a threat to the current hemophilia market. … Read more
WASHINGTON, June 21, 2023 /PRNewswire/ — The National Resident Matching Program (NRMP) has chosen an outstanding group of candidates with a diverse set of backgrounds and experiences to join its 20-person Board of Directors. Their terms will begin July 1, 2023. “We’re thrilled to welcome Dr. LaFemina, Dr. Mariano, Dr. Mosquera Vasquez, Ms. Adeyeri, and … Read more
SAN DIEGO, June 21, 2023 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on June 20, 2023, the Human Capital Management Committee of Avidity’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 23,650 … Read more
NEW YORK, June 21, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee and the Board of Directors, as a material inducement … Read more
MCKINNEY, Texas, June 21, 2023 /PRNewswire/ — Globe Life Inc. (NYSE: GL) announced that its Board of Directors has declared a quarterly dividend of $.2250 per share on all of the outstanding common stock of the Company held of record as of close of business of the Company’s transfer agent on July 5, 2023. The dividend will … Read more